Skip to content

A clinical randomized controlled trial of transcranial magnetic stimulation in the treatment of depression under different modes

A clinical randomized controlled trial of transcranial magnetic stimulation in the treatment of depression under different modes

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044363
Enrollment
Unknown
Registered
2021-03-17
Start date
2021-03-22
Completion date
Unknown
Last updated
2021-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

major depression

Interventions

control group:sham stimulation
experimental group:theta burst stimulation

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Meet the conditions for refractory depression (including unipolar or bipolar depression): (1) Have used 2 or more antidepressants; (2) Take full dose and full course of medication (use at least two drugs); 2. All patients gave informed consent; 3. The anesthesia risk assessment of ECT is high-risk, ECT is intolerant, and the side effects of ECT are obvious, because other reasons are unwilling to perform ECT or those who have poor efficacy after ECT.

Exclusion criteria

Exclusion criteria: 1. Those who have a history of epilepsy or a family history of epilepsy; 2. Those who have a history of traumatic brain injury or a history of craniocerebral surgery in the past year; 3. Those who have a metal foreign body in the skull or have a pacemaker; 4. Those who cannot cooperate to complete the treatment due to physical illness; 5. Those who cannot cooperate with the investigator due to cognitive impairment.

Design outcomes

Primary

MeasureTime frame
Cortisol;ACTH;Blood routine;Interleukin-1;Interleukin-8;Interleukin-6;C reactive protein;TNF-a;FT3;FT4;TSH;

Countries

China

Contacts

Public ContactDu Lian

The First Affiliated Hospital of Chongqing Medical University

405216810@qq.com+86 13108926750

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026